Suppr超能文献

普萘洛尔在甲状腺毒症外科治疗中的应用

Propranolol in the surgical management of thyrotoxicosis.

作者信息

Bewsher P D, Pegg C A, Stewart D J, Lister D A, Michie W

出版信息

Ann Surg. 1974 Nov;180(5):787-90. doi: 10.1097/00000658-197411000-00014.

Abstract

Forty-nine thyrotoxic patients prepared for partial thyroidectomy with the beta-adrenoceptor blocking drug, propranolol, and iodine are compared with 42 patients prepared with carbimazole and iodine. The age and sex distribution of the two groups were comparable, but patients with obstructive airways disease and possible cardiac insufficiency were excluded from preparation with propranolol. The mean duration of preoperative treatment with propranolol was 40 days, compared with 89 days for carbimazole. Propranolol treated patients had lower pulse rates before and after operation. The serum PB(127)I values immediately before and after operation were higher in the propranolol group than in the carbimazole group, but were the same in both groups one and four months after operation. The incidence of hypothyroidism at one year after operation was 30% in the carbimazole prepared patients and 31% in the propranolol patients. Serum calcium levels were higher in the propranolol group at the time of operation. No adverse effects from the use of propranolol and at operation the thyroid gland prepared with propranolol was firmer, less friable, more easily mobilised and less likely to bleed than the gland prepared with carbimazole. There is, consequently, less risk of damage to the parathyroid glands and recurrent laryngeal nerves. However, the basal metabolic rate remains high on propranolol therapy and very careful supervision is advised.

摘要

将49例准备接受部分甲状腺切除术的甲状腺毒症患者,使用β-肾上腺素能阻滞剂普萘洛尔和碘进行准备,与42例使用卡比马唑和碘进行准备的患者进行比较。两组的年龄和性别分布具有可比性,但患有阻塞性气道疾病和可能存在心脏功能不全的患者被排除在普萘洛尔准备组之外。普萘洛尔术前治疗的平均持续时间为40天,而卡比马唑为89天。接受普萘洛尔治疗的患者术前和术后脉搏率较低。普萘洛尔组术前和术后即刻的血清PB(127)I值高于卡比马唑组,但术后一个月和四个月时两组相同。术后一年,卡比马唑准备组患者甲状腺功能减退的发生率为30%,普萘洛尔组为31%。手术时普萘洛尔组的血清钙水平较高。使用普萘洛尔未出现不良反应,且在手术时,用普萘洛尔准备的甲状腺比用卡比马唑准备的甲状腺更坚实、更不易碎、更易于游离且出血可能性更小。因此,甲状旁腺和喉返神经受损的风险更低。然而,普萘洛尔治疗期间基础代谢率仍较高,建议进行非常仔细的监测。

相似文献

7
The surgical management of thyrotoxicosis.甲状腺毒症的外科治疗
Br J Surg. 1973 Oct;60(10):765-9. doi: 10.1002/bjs.1800601004.
8
Control of hypercalcaemia in thyrotoxicosis.甲状腺毒症中高钙血症的控制
Postgrad Med J. 1979 Dec;55(654):891-3. doi: 10.1136/pgmj.55.650.891.
9
Whither thyrotoxicosis?甲状腺毒症何去何从?
Br J Surg. 1975 Sep;62(9):673-82. doi: 10.1002/bjs.1800620902.

本文引用的文献

1
GUANETHIDINE IN HYPERTHYROIDISM.胍乙啶治疗甲状腺功能亢进症
JAMA. 1964 Aug 24;189:609-12. doi: 10.1001/jama.1964.03070080015003.
6
Propranolol and serum calcium in thyrotoxicosis.甲状腺毒症中的普萘洛尔与血清钙
Br Med J. 1970 Aug 29;3(5721):525-6. doi: 10.1136/bmj.3.5721.525-d.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验